BTX insider filings
BlackRock Technology & Private Equity Term Trust — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-17. Screen BTX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Mahoney Francis C. — Director | 1 | — | — | — |
Recent insider filings — BlackRock Technology & Private Equity Term Trust
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 3 | Mahoney Francis C. — Director | Holdings only — no transactions reported | EDGAR |
| 2026-02-03 | 4 | Menge Steven Reid | Grant/award (A): 4,136.94 (derivative) @ $7.85 | EDGAR |
| 2026-02-03 | 4 | Kim Tony | Grant/award (A): 29,270.83 (derivative) @ $7.85 | EDGAR |
| 2025-12-22 | 4 | Fairbairn Robert W — Director | Sale (S): 21,936 @ $6.52 · Sale (S): 0.71 @ $6.55 | EDGAR |
| 2025-07-10 | 4 | Saba Capital Management, L.P. — 10% owner Weinstein Boaz — 10% owner | Other (J): 60,675,395 @ $7.49 | EDGAR |
| 2022-09-21 | 4 | Sidhu Roger — Chief Medical Officer | Option exercise (M): 20,163 · Option exercise (M): 20,163 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Fiore Gregory — Director | Grant/award (A): 95,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Angel Matthew — Interim President and CEO, Director | Grant/award (A): 2,487,003 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Wexler William A. — Director | Grant/award (A): 152,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Singer Nicholas Jason — Director | Grant/award (A): 146,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Cherington Charles — Director | Grant/award (A): 215,100 (derivative) @ $0 · Grant/award (A): 165,800 (derivative) @ $0 | EDGAR |
| 2022-06-29 | 4 | DAmour Kevin — Chief Scientific Officer | Option exercise (M): 17,573 · Tax withholding (F): 6,077 @ $0.55 · Option exercise (M): 17,573 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | Gurrola Sandra M — Vice President of Finance | Option exercise (M): 8,750 · Tax withholding (F): 3,586 @ $0.48 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Jackson Andrew C. — Chief Financial Officer | Grant/award (A): 664,800 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4/A | Sidhu Roger — Chief Medical Officer | Grant/award (A): 142,100 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4/A | Sial Jay — Chief Administration Officer | Grant/award (A): 117,200 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4/A | DAmour Kevin — Chief Scientific Officer | Grant/award (A): 138,400 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4/A | Federoff Howard J. — CEO & President, Director | Grant/award (A): 413,700 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4/A | Gurrola Sandra M — Vice President of Finance | Grant/award (A): 114,500 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | Sidhu Roger — Chief Medical Officer | Grant/award (A): 142,100 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | Sial Jay — Chief Administration Officer | Grant/award (A): 117,200 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | DAmour Kevin — Chief Scientific Officer | Grant/award (A): 138,400 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | Federoff Howard J. — CEO & President, Director | Grant/award (A): 413,700 (derivative) @ $0 | EDGAR |
| 2022-03-15 | 4 | Gurrola Sandra M — Vice President of Finance | Grant/award (A): 114,500 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | Redman Heather B — Director | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | ENRIGHT ERIN S. — Director | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-12-10 | 4 | Greenwood Luba — Director | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-12-10 | 4 | Cherington Charles — Director | Other (J): 92 @ $0 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-12-10 | 4 | Mohr Erich — Director | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-12-10 | 4 | LANGER DENNIS — Director | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | Sidhu Roger — See Remarks | Grant/award (A): 161,300 (derivative) @ $0 · Grant/award (A): 80,650 (derivative) @ $0 | EDGAR |
| 2021-08-20 | 4 | DENNY GEORGE P III — 10% owner | Sale (S): 75,000 @ $16.06 · Purchase (P): 1 @ $14.35 · Purchase (P): 1 @ $14.11 · Purchase (P): 1 @ $11.99 | EDGAR |
| 2021-07-19 | 4 | Sial Jay — See Remarks | Grant/award (A): 71,000 (derivative) @ $0 · Grant/award (A): 35,700 (derivative) @ $0 | EDGAR |
| 2021-06-30 | 4 | DAmour Kevin — See Remarks | Grant/award (A): 140,580 (derivative) @ $0 · Grant/award (A): 70,290 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | Gurrola Sandra M — Vice President of Finance | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Cherington Charles — Director, 10% owner | Sale (S): 200,000 @ $15.73 · Sale (S): 198,000 @ $15.74 · Sale (S): 2,000 @ $16.30 | EDGAR |
| 2021-04-20 | 4 | Federoff Howard J. — See Remarks, Director | Grant/award (A): 2,627,915 (derivative) @ $0 · Grant/award (A): 597,253 (derivative) @ $0 | EDGAR |
| 2021-03-26 | 4 | Wolff Allen — Former Director and CEO, Director | Tax withholding (F): 9,944 @ $2.67 | EDGAR |
| 2021-03-26 | 4 | Gurrola Sandra M — Former SVP of Finance | Tax withholding (F): 6,094 @ $2.67 | EDGAR |
Recent 8-K events — BlackRock Technology & Private Equity Term Trust
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-09-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-02-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs